Table 2.
Hospitalized patients | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Study | Year | Country | Language | Patient number | Survivor | Nonsurvivor | Male N (%) | T2DM N (%) | HTN N (%) | COPD N (%) | CHF/CAD N (%) | CKD N (%) | Mean age | Cutoff | AUC | TP | FP | FN | TN | SEN % | SPEC % |
Tatum et al.44 | 2020 | AMERICA | ENGLISH | 125 | 102 | 23 | 45.6 | NA | NA | NA | NA | NA | 58.7 | 10 | 0.71 | 12 | 11 | 98 | 4 | 0.52 | 0.97 |
Chen et al.48 | 2020 | CHINA | ENGLISH | 681 | 577 | 104 | 53.2 | 16.7 | 43 | 2.2 | 11.7 | 4 | 65 | 6.7 | 0.86 | 87 | 17 | 447 | 130 | 0.84 | 0.77 |
Ok et al.11 | 2020 | TURKEY | ENGLISH | 139 | 126 | 13 | 44.4 | 17.9 | 23.7 | NA | 13.6 | NA | 55.5 | 5.7 | 0.85 | 10 | 3 | 113 | 13 | 0.83 | 0.90 |
Asghar et al.36 | 2020 | PAKISTAN | ENGLISH | 100 | 78 | 22 | 69 | 41 | 32 | 3 | 13 | 10 | 52.6 | 4.2 | 0.81 | 19 | 3 | 48 | 30 | 0.91 | 0.63 |
Yan et al.49 | 2020 | CHINA | ENGLISH | 1,004 | 964 | 40 | 49.1 | 10.6 | 23.4 | 0.79 | 7.47 | 10.15 | NA | 11.8 | 0.95 | 39 | 1 | 752 | 212 | 0.98 | 0.78 |
Basbus et al.38 | 2020 | SPAIN | SPANISH | 131 | 112 | 9 | 54.1 | 6.9 | 30.5 | 3.8 | 5.9 | NA | 52 | 3 | NA | 7 | 2 | 69 | 43 | 0.78 | 0.62 |
Li et al.39 | 2020 | CHINA | CHINESE | 93 | 62 | 31 | 59.13 | 10.75 | 12.9 | 6.45 | NA | NA | 62.1 | 11.3 | 0.92 | 27 | 4 | 52 | 10 | 0.90 | 0.84 |
Song et al.50 | 2020 | CHINA | CHINESE | 84 | 42 | 42 | 66.66 | NA | NA | NA | NA | NA | 66.5 | 6.1 | 0.87 | 32 | 10 | 37 | 5 | 0.76 | 0.88 |
Zhang et al.30 | 2020 | CHINA | CHINESE | 154 | 127 | 27 | 52.59 | 13.63 | 13.63 | 5.84 | 10.38 | 7.79 | 69.2 | 9.4 | 0.86 | 20 | 7 | 116 | 11 | 0.76 | 0.92 |
Ramos-penafiel et al.15 | 2020 | MEXICO | ENGLISH | 125 | 81 | 44 | 64 | 21.6 | 19.2 | NA | NA | NA | 51 | 13 | 0.72 | 26 | 18 | 48 | 33 | 0.60 | 0.60 |
Xu et al.51 | 2020 | CHINA | ENGLISH | 76 | 44 | 32 | 60.53 | 19.74 | 35.53 | 2.63 | 9.21 | 6.58 | 59.1 | 3.59 | 0.69 | 30 | 2 | 17 | 27 | 0.94 | 0.39 |
Ye et al.52 | 2020 | CHINA | ENGLISH | 349 | 297 | 52 | 49.6 | 16.3 | 29.5 | 12.6 | 4.6 | 4 | 62 | 7.13 | 0.86 | 41 | 11 | 243 | 54 | 0.80 | 0.82 |
Wang et al.16 | 2020 | CHINA | ENGLISH | 131 | 119 | 12 | 42.7 | 21.4 | 39.7 | NA | NA | NA | 64 | 13.87 | 0.963 | 10 | 2 | 107 | 12 | 0.90 | 0.90 |
Zeng et al.53 | 2021 | CHINA | ENGLISH | 352 | 116 | 15 | 53.9 | NA | NA | NA | NA | NA | NA | 7.19 | 0.828 | 13 | 2 | 74 | 42 | 0.93 | 0.64 |
Eslamijouybari et al.54 | 2020 | IRAN | ENGLISH | 527 | 429 | 98 | 44 | NA | NA | NA | NA | NA | NA | 6.55 | 0.703 | 63 | 35 | 268 | 161 | 0.65 | 0.63 |